Loading data for TMO — first visit, this takes a few seconds.

Thermo Fisher Scientific Inc. (TMO)

NYSE: TMO · Real-Time Price · USD

609.82

+6.64 (1.10%)

At close: Sep 11, 2026, 3:59 PM

609.82

+0.00%

After-hours: 6:06 PM

Alert

The price, the headline numbers and the latest news, in one place.

1.10% (1D)

Bid	612.69
Market Cap	225B
Revenue (ttm)	46.3B
Net Income (ttm)	6.97B
	0.85
	18.6
	32.79
	22.15
P/B (ttm)	4.28
P/S (ttm)	4.87
Earnings Date	Oct 21, 2026

Ask	612.89
Volume	1,784,261
Avg. Volume (20D)	2,010,253
Open	609.96
Previous Close	603.18
Day's Range	606.15 - 615.24
52-Week Range	435.27 - 647.00
Analyst	n/a
Price Target	n/a
Dividends	$1.88 (0.31%)
Ex-Dividend Date	Sep 15, 2026

About TMO

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research;...

[Read more]

Industry Diagnostics & Research

Sector Healthcare

IPO Date Mar 17, 1980

Employees 125,000

Stock Exchange NYSE

Ticker Symbol TMO

Website https://www.thermofisher.com

Full Company Profile

Financial Performance

In 2025, Thermo Fisher Scientific's revenue was 44.56B, an increase of 3.91% compared to the previous year's 42.88B. Earnings were 6.7B, an increase of 5.82%.

Financial Statements

Earnings Surprise

Thermo Fisher Scientific has released their quarterly earnings on Jul 23, 2026:

Revenue of $11.99B misses estimates by $0, with 10.50% YoY growth.
EPS of 6.03 exceeds estimates by 0.32, with 12.50% YoY growth.

Next Earnings Release

Thermo Fisher Scientific Inc. is scheduled to release its earnings on Oct 21, 2026, before market opens.
Analysts project revenue of ... Upgrade

Why Price Moved

News

3 days ago · MT Newswires

Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says

Thermo Fisher Scientific (TMO) and Danaher (DHR) are likely to return to mid-single-digit organic re

3 days ago · The Fly

Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls

3 days ago · 24/7 Wall St.

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Abercrombie & Fitch, Affirm Holdings, Eagle Materials, Klarna Group, Martin Marietta Materials, Oklo, Qualcomm, Robinhood Markets, Ulta Beauty, and More

Stocks took a beating Tuesday as surging oil prices and looming inflation data rattled every corner of the market, and now Wall Street analysts are reshuffling their calls on names ranging from nuclea...

4 days ago · Trefis

ILMN Stock Keeps Climbing. Should You Climb On?

A gene sequencing leader is on a powerful run fueled by real business quality, forcing investors to decide if the engine has more power than the price tag already reflects.

1 week ago · Zacks

Should You Continue to Hold TMO Stock in Your Portfolio?

Thermo Fisher's growth is gaining momentum as acquisitions strengthen its life sciences reach, but macro risks and competition remain concerns.

Page 1 of 2

Thermo Fisher Scientific Inc. (TMO)